Application

19307513 · Sublingual Formulation of Anticancer Compound for Use in the Treatment of Autoimmune Neurodegenerative Diseases

Filed 2025-08-22 · Pending The official file ↗ · Art unit 1619 · Examiner Garen Gotfredson Typical · CPC A61K 47/6951 · Vektor Pharma TF GmbH · CHALKER FLORES, LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.3 mo

to disposition n/a

Statutes raised

103 112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.